Date & Time: February 21, 2023 | 9AM PT (12PM ET)
Location: Online

This webinar, Driving PGx Adoption: Proven Implementations to Reduce ADRs by 30% (The PREPARE Study), presented in partnership with GenXys, will be led by industry experts Dr. George Patrinos, Professor and Head of Laboratory at the University of Patras and Editor-in-Chief of The Pharmacogenomics Journal, Dr. Sara Rogers, President of the American Society for Pharmacovigilance and Clinical Assistant Professor at Texas A&M University, and Dr. Richard Turner, Director – Physician in Genomic Sciences at GSK.

Topics include:

• Proof points which help in pharmacogenetics (PGx) adoption
• The Pre-emptive Pharmacogenomic Testing for Preventing Drug Reactions (PREPARE) study
• The outcomes which show a 30% reduction in ADRs
• Live Q&A